Grey matter volumes in treatment naïve vs. chronically treated children with attention deficit/hyperactivity disorder: a combined approach

[1]  G. Salmon,et al.  Attention deficit hyperactivity disorder. , 2018, British journal of hospital medicine.

[2]  L. Romo,et al.  [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?]. , 2015, L'Encephale.

[3]  M. Brammer,et al.  Effects of Stimulants on Brain Function in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis , 2014, Biological Psychiatry.

[4]  W. Barbaresi,et al.  Childhood ADHD and Risk for Substance Dependence in Adulthood: A Longitudinal, Population-Based Study , 2014, PloS one.

[5]  P. Lichtenstein,et al.  Stimulant ADHD medication and risk for substance abuse. , 2014, Journal of child psychology and psychiatry, and allied disciplines.

[6]  Sara R. Jones,et al.  Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration , 2014, Neuropharmacology.

[7]  M. Chakravarty,et al.  Mapping the development of the basal ganglia in children with attention-deficit/hyperactivity disorder. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

[8]  Karl J. Friston,et al.  Methylphenidate and brain activity in a reward/conflict paradigm: Role of the insula in task performance , 2014, European Neuropsychopharmacology.

[9]  John O. Willis,et al.  Wechsler Abbreviated Scale of Intelligence , 2014 .

[10]  Colm G. Connolly,et al.  A voxel-based morphometry study of young occasional users of amphetamine-type stimulants and cocaine. , 2014, Drug and alcohol dependence.

[11]  S. Durston,et al.  MR imaging of the effects of methylphenidate on brain structure and function in Attention-Deficit/Hyperactivity Disorder , 2013, European Neuropsychopharmacology.

[12]  K. Humphreys,et al.  Stimulant medication and substance use outcomes: a meta-analysis. , 2013, JAMA psychiatry.

[13]  R. Kydd,et al.  Striatal Volume Increases in Active Methamphetamine-Dependent Individuals and Correlation with Cognitive Performance , 2012, Brain sciences.

[14]  N. Volkow.  Long-Term Safety of Stimulant Use for ADHD: Findings from Nonhuman Primates , 2012, Neuropsychopharmacology.

[15]  Michael P Milham,et al.  Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. , 2012, The American journal of psychiatry.

[16]  R. Klein,et al.  Psychostimulants Act Within the Prefrontal Cortex to Improve Cognitive Function , 2012, Biological Psychiatry.

[17]  N. Skokauskas,et al.  Meta‐analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects , 2012, Acta psychiatrica Scandinavica.

[18]  B. Vitiello,et al.  Stimulant medication use in children: a 12-year perspective. , 2012, The American journal of psychiatry.

[19]  Yong He,et al.  Brain gray matter deficits at 33-year follow-up in adults with attention-deficit/hyperactivity disorder established in childhood. , 2011, Archives of general psychiatry.

[20]  Katya Rubia,et al.  Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. , 2011, The American journal of psychiatry.

[21]  J. Wiltfang,et al.  Disentangling structural brain alterations associated with violent behavior from those associated with substance use disorders. , 2011, Archives of general psychiatry.

[22]  E. Parise,et al.  Juvenile Administration of Concomitant Methylphenidate and Fluoxetine Alters Behavioral Reactivity to Reward- and Mood-Related Stimuli and Disrupts Ventral Tegmental Area Gene Expression in Adulthood , 2011, The Journal of Neuroscience.

[23]  Anderson M. Winkler,et al.  Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies , 2010, NeuroImage.

[24]  B. Peterson,et al.  Basal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorder. , 2010, The American journal of psychiatry.

[25]  J. Morrison,et al.  The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens , 2010, Trends in Neurosciences.

[26]  Christian Gaser,et al.  Auditory hallucinations and brain structure in schizophrenia: voxel-based morphometric study , 2010, British Journal of Psychiatry.

[27]  M. Mallar Chakravarty,et al.  Morphological abnormalities of the thalamus in youths with attention deficit hyperactivity disorder. , 2010, The American journal of psychiatry.

[28]  Robert M. Kessler,et al.  Mesolimbic Dopamine Reward System Hypersensitivity in Individuals with Psychopathic Traits , 2010, Nature Neuroscience.

[29]  Anne S. Bassett,et al.  Voxel-based morphometry and automated lobar volumetry: The trade-off between spatial scale and statistical correction , 2010, NeuroImage.

[30]  M. Semrud-Clikeman,et al.  A Magnetic Resonance Imaging Study of the Cerebellar Vermis in Chronically Treated and Treatment-Naïve Children with Attention-Deficit/Hyperactivity Disorder Combined Type , 2009, Biological Psychiatry.

[31]  C. Perrone-Capano,et al.  Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology , 2009, Genes, brain, and behavior.

[32]  Angus C Nairn,et al.  Methylphenidate-induced dendritic spine formation and ΔFosB expression in nucleus accumbens , 2009, Proceedings of the National Academy of Sciences.

[33]  F. Castellanos,et al.  Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. , 2008, The American journal of psychiatry.

[34]  James J. Pekar,et al.  Functional Magnetic Resonance Imaging Evidence for Abnormalities in Response Selection in Attention Deficit Hyperactivity Disorder: Differences in Activation Associated with Response Inhibition but Not Habitual Motor Response , 2008, Journal of Cognitive Neuroscience.

[35]  J. Lancaster,et al.  Volumetric MRI differences in treatment-naïve vs chronically treated children with ADHD , 2006, Neurology.

[36]  L. Kroutil,et al.  Nonmedical use of prescription stimulants in the United States. , 2006, Drug and alcohol dependence.

[37]  Danielle N. Pappas.  ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation , 2006 .

[38]  Alan C. Evans,et al.  Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. , 2006, Archives of general psychiatry.

[39]  S. Faraone,et al.  Attention-deficit hyperactivity disorder , 2005, The Lancet.

[40]  Ali A. Bonab,et al.  In Vivo Neuroreceptor Imaging in Attention-Deficit/Hyperactivity Disorder: A Focus on The Dopamine Transporter , 2005, Biological Psychiatry.

[41]  D. Segal,et al.  Stimulant Actions in Rodents: Implications for Attention-Deficit/Hyperactivity Disorder Treatment and Potential Substance Abuse , 2005, Biological Psychiatry.

[42]  V. Calhoun,et al.  Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia , 2005, Schizophrenia Research.

[43]  Bryan Kolb,et al.  Structural plasticity associated with exposure to drugs of abuse , 2004, Neuropharmacology.

[44]  Keith M. Shafritz,et al.  The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. , 2004, The American journal of psychiatry.

[45]  M. Barrot,et al.  Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood , 2003, Biological Psychiatry.

[46]  Stewart H Mostofsky,et al.  Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder , 2002, Biological Psychiatry.

[47]  Alan C. Evans,et al.  Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. , 2002, JAMA.

[48]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[49]  B Kolb,et al.  Persistent Structural Modifications in Nucleus Accumbens and Prefrontal Cortex Neurons Produced by Previous Experience with Amphetamine , 1997, The Journal of Neuroscience.

[50]  Mary Ganguli,et al.  Diagnostic Interview Schedule. , 1982, Archives of general psychiatry.

[51]  J. Endicott,et al.  A diagnostic interview: the schedule for affective disorders and schizophrenia. , 1978, Archives of general psychiatry.

[52]  T. Villemonteix,et al.  [is Emotional Dysregulation a Component of Attention- Deficit/hyperactivity Disorder (adhd)?] , 2022 .

[53]  E. Luders,et al.  Voxel-Based Morphometry , 2015 .

[54]  M. Frydenberg,et al.  ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study. , 2014, Addictive behaviors.

[55]  J. Ramos-Quiroga,et al.  Stimulant drugs trigger transient volumetric changes in the human ventral striatum , 2012, Brain Structure and Function.

[56]  Alan C. Evans,et al.  Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder. , 2009, The American journal of psychiatry.

[57]  Robert Reid,et al.  Adhd Rating Scale-IV: Checklists, Norms, and Clinical Interpretation , 1998 .